Form 4: MannKind Director Boosts Stake with 35,000 Share Purchase
Insider Trading Report
MannKind Corp. Director Anthony C. Hooper acquired 35,000 shares of common stock at $3.27 per share through a company plan.
Summary
- Anthony C. Hooper, a Director of MannKind Corp. (MNKD), acquired 35,000 shares of common stock.
- The transaction occurred on March 1, 2026, at a price of $3.27 per share.
- The shares were purchased through the Issuer's Market Price Stock Purchase Plan.
- Following this transaction, Mr. Hooper directly owns 236,153 shares of MannKind Corp. common stock.
- The purchase was approved by the Company's Board of Directors on March 1, 2026.
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a strong positive signal, as a director's personal investment in company stock typically indicates confidence in future performance and valuation.
Positives
- A Director's purchase of company stock signals confidence in the company's future prospects and valuation.
- The acquisition of 35,000 shares represents a significant investment by a key insider.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that insider buying, especially by a director, is often interpreted by the market as a positive signal, suggesting that those closest to the company believe its shares are undervalued or that significant positive developments are anticipated. This action by a MannKind director could be seen as a vote of confidence in the company's strategic direction and product pipeline within the biotechnology and pharmaceutical sector.
Comparison to Industry Standards
- StockSavvy.ai notes that insider buying activity is a common occurrence across industries. While the specific amount of shares purchased by Anthony C. Hooper is significant for an individual, it is difficult to compare directly to other companies without knowing the director's total compensation, net worth, or the overall market capitalization of MannKind Corp.
- However, similar insider purchases have been observed in companies like Pfizer (PFE) or Eli Lilly (LLY) where executives or directors acquire shares, often through company plans, signaling belief in future growth or product success.
Related Party Transactions
- The purchase of 35,000 shares by Director Anthony C. Hooper through the Issuer's Market Price Stock Purchase Plan constitutes a related party transaction.
Stakeholder Impact
- Shareholders may view this as a positive signal, potentially increasing confidence and demand for the stock.
- Employees could interpret this as a sign of stability and positive future prospects for the company.
Key Dates
| Date | Description |
|---|---|
| 03/01/2026 | Date of earliest transaction and Board of Directors approval for the stock purchase. |
| 03/03/2026 | Signature date of the reporting person. |
Recommendation
buyA director's decision to personally invest a significant amount in the company's stock, especially through a company-approved plan, is a strong indicator of internal confidence. This insider buying suggests that management believes the stock is undervalued or expects positive developments, making it a compelling 'buy' signal for seasoned investors.
Keywords
MannKind Corp, MNKD, Anthony C. Hooper, Director, Insider Buying, Stock Purchase, SEC Form 4, Beneficial Ownership, Equity Acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.